Synapse - David Hyman

Results (19)

Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy

Meeting Abstract

Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
Blood (2019)

Fulltext@MSK | Save

Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms

Meeting Abstract

Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
Blood (2018)

Fulltext@MSK | Save

Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis

Meeting Abstract

Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
Blood (2018)

Fulltext@MSK | Save

Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies

Meeting Abstract

Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
Blood (2017)

Fulltext@MSK | Save

Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling

Meeting Abstract

Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
Blood (2017)

Fulltext@MSK | Save

Phase 2 trial of single-agent cobimetinib for adults with BRAF V600-mutant and wild-type histiocytic disorders

Meeting Abstract

Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R. K.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
Blood (2017)

Fulltext@MSK | Save

Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses

Meeting Abstract

Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
Blood (2016)

Fulltext@MSK | Save

Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles

Meeting Abstract

Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
Blood (2016)

Fulltext@MSK | Save

Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study

Meeting Abstract

Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
Blood (2016)

Fulltext@MSK | Save

Vemurafenib (VEM) in relapsed refractory multiple myeloma harboring BRAF(V600) mutations (V600m): A cohort of the histology-independent VE-basket study

Meeting Abstract

Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez-Fernandez, M. E.; Wolf, J. S.; Sirzen, F.; Yee, A.; more...
Blood (2015)

Fulltext@MSK | Save